Market closed

Pharvaris/$PHVS

14:30
16:10
17:45
19:25
21:00
1D1W1MYTD1Y5YMAX

About Pharvaris

Pharvaris NV is a clinical-stage company. It is focused on the discovery and development and commercialization of therapies for rare diseases with significant unmet need, initially focused on angioedema and other bradykinin-mediated diseases. The company's activities are considered to be one segment which comprises the discovery, development and commercialization of oral bradykinin-B2-receptor antagonists .

Ticker

$PHVS
Trading on

Industry

Pharmaceuticals

Employees

83

Pharvaris Metrics

BasicAdvanced
$1.1B
Market cap
-
P/E ratio
-$2.52
EPS
-3.10
Beta
-
Dividend rate
$1.1B
-3.1
$33.00
$15.00
87K
18.447
18.136
0.013
0.042
-26.79%
-45.05%
3.45
3.45
-9.687
-12.76%
0.21%

What the Analysts think about Pharvaris

Analyst Ratings

Analyst ratings (Buy, Hold, Sell) for Pharvaris stock.

Pharvaris Financial Performance

Income Statement

Revenues and expenses
QuarterlyAnnual
Q3 24
QoQ growth
Revenue
$37B
-39.75%
Net income
$45B
107.52%
Profit margin
37.65%
6.78%

Pharvaris Earnings Performance

Earnings per share (EPS)

Company profitability
QuarterlyAnnual
Q4 23
Q1 24
Q2 24
Q3 24
Q4 24
Actual
$3.69
$2.85
$2.45
$2.42
-
Expected
$3.55
$2.61
$2.05
$2.31
$3.94
Surprise
3.94%
9.20%
19.51%
4.63%
-
Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Actual execution price may vary. Past performance is not indicative of future results. Your return may be affected by currency fluctuations and applicable fees and charges. Capital at risk.
Real time US market data is a consolidated feed of IEX, NYSE National, NYSE Chicago, Nasdaq BX and Nasdaq PSX order books provided by Polygon. After-hours US market data is 15 minutes delayed and may differ significantly from the actual tradable price at market open.

Buy $PHVS

$

Sign up or log in to buy
Capital at risk
Market closed

Upcoming events

No upcoming events

FAQs

What’s the current market cap for Pharvaris stock?

Pharvaris (PHVS) has a market cap of $1.1B as of November 13, 2024.

What is the P/E ratio for Pharvaris stock?

The price to earnings (P/E) ratio for Pharvaris (PHVS) stock is 0 as of November 13, 2024.

Does Pharvaris stock pay dividends?

No, Pharvaris (PHVS) stock does not pay dividends to its shareholders as of November 13, 2024.

When is the next Pharvaris dividend payment date?

Pharvaris (PHVS) stock does not pay dividends to its shareholders.

What is the beta indicator for Pharvaris?

Pharvaris (PHVS) has a beta rating of -3.1. This means that it has an inverse relation to market volatility.